CTRI/2023/05/053058已完成Unknown
A study to evaluate the ophthalmologic safety of the hydrating mist in healthy female subjects after daily use (3 days).
DPKA Universal Consumer Ventures Private Limited0 个研究点目标入组 33 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Female healthy adult subjects with age 18-45 years
- •2.Subject is in good health condition.
- •3.Subjects willing to refrain from use of other similar products during the study.
排除标准
- •1.Female with age less than 18 or more than 45 years of age
- •2.Pregnant/lactating mothers
- •3.Subjects with eye infection and sensitive eyes
研究者
相似试验
已完成
Unknown
Safety checking of Product on eyesCTRI/2023/03/050979DPKA UNIVERSAL CONSUMER VENTURES PRIVATE LIMITED33
尚未招募
不适用
Evaluation of eye safety of test productCTRI/2022/07/043782ONESTO LABS PVT LTD
尚未招募
Unknown
Assessment of Ophthalmological safety of skin care productCTRI/2023/11/059530DPKA UNIVERSAL CONSUMER VENTURES PRIVATE LIMITED
未知
不适用
Clinical study about the ocular administration of the anti-VEGF antibody for the retinopathy of prematurityretinopathy of prematurityJPRN-UMIN000025361ara Medical University20
已完成
3 期
To assess the ability of retina specialists to successfully administer Aflibercept in eye.CTRI/2023/10/059113Biosimilar collaborations Ireland Limited35